Robert Haigh
Fondatore presso KalVista Pharmaceuticals Ltd.
Provenienza dei contatti di primo grado di Robert Haigh
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
CHAIN Biotechnology Ltd.
 CHAIN Biotechnology Ltd. BiotechnologyHealth Technology CHAIN Biotechnology Ltd. develops new clostridium-based microbial technology for high value healthcare products. It produces novel 2nd generation live bio therapeutic products (LBPs) for chronic gut-related diseases, such as Inflammatory Bowel Disease (IBD). The company was founded by Edward Green and Basil Omar in 2014 and is headquartered in Marlow, the United Kingdom.
5
| Holding Company | Biotechnology | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Robert Haigh tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ORACLE CORPORATION | Packaged Software | Corporate Officer/Principal | |
| AKSYS LTD. | Financial Conglomerates | Director/Board Member | |
FemRx, Inc.
 FemRx, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, FemRx, Inc. is a company that produces medical products for gynecological disorders. The company is based in Sunnyvale, CA. FemRx was acquired by Johnson & Johnson on November 06, 1998 for $20.99 million. | Medical Specialties | Director of Finance/CFO | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
VNUS Medical Technologies, Inc.
 VNUS Medical Technologies, Inc. Medical SpecialtiesHealth Technology VNUS Medical Technologies, Inc. provides medical devices and procedures for the minimally invasive treatment of venous reflux disease, an underlying cause of varicose veins. Venous reflux disease results in symptoms such as leg pain, swelling, fatigue, skin ulcers, and painful varicose veins. The company was founded on January 31, 1995 and is headquartered in San Jose, CA. | Medical Specialties | Director/Board Member | |
TRIA Beauty, Inc.
 TRIA Beauty, Inc. Medical SpecialtiesHealth Technology TRIA Beauty, Inc. provides light based therapeutic beauty devices. It offers TRIA Laser Hair Removal System for laser removal of hair and TRIA Skin Perfecting Blue Light for mild to moderate inflammatory acne with a proprietary cleanser and serum for overall complexion improvement. The company was founded in 2003 by Tobin C. Island, Robert E. Grove, Jonathon T. Pearson and Mark V. Weckwerth and is headquartered in Dublin, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Ceptaris Therapeutics, Inc.
 Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| MINERVA SURGICAL, INC. | Medical Specialties | Director/Board Member | |
Vicept Therapeutics, Inc.
 Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin | |
| CARCLO PLC | Miscellaneous Manufacturing | Director/Board Member | |
Highland Timber Plc
 Highland Timber Plc Forest ProductsNon-Energy Minerals Highland Timber Plc owns forest estates. The company is headquartered in Great Barrington, the United Kingdom. | Forest Products | Chairman | |
| SCHRODER UK MID CAP FUND PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
| University of Cambridge | College/University | Graduate Degree | |
Neomend, Inc.
 Neomend, Inc. BiotechnologyHealth Technology Neomend, Inc. develops surgical wound healing products. It offers adhesion prevention products for hospitals and medical facilities. The company was founded in 1999 and is headquartered in Irvine, CA. | Biotechnology | Director/Board Member | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Chairman | |
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Corporate Secretary Corporate Officer/Principal Founder Director/Board Member | |
| Praxon, Inc. | Director of Finance/CFO | ||
| Government of Saint Lucia | Sovereign | Corporate Officer/Principal | |
Museum of Modern Art Oxford
 Museum of Modern Art Oxford Other Consumer ServicesConsumer Services Museum of Modern Art Oxford operates as a museum. The company was founded in 1965 and is headquartered in Oxford, the United Kingdom. | Other Consumer Services | Chairman | |
| David Geffen School of Medicine | College/University | Doctorate Degree | |
| Institute of Chartered Foresters | Corporate Officer/Principal | ||
Avilex Pharma ApS
 Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director/Board Member | |
Rockley Group China Co. Ltd.
 Rockley Group China Co. Ltd. Investment ManagersFinance Rockley Group China Co. Ltd. is the private equity and venture capital firm. The firm was founded in 1995 and headquartered in Beijing, China. | Investment Managers | Director/Board Member | |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Private Equity Investor | |
CMR Surgical Ltd.
 CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Director/Board Member | |
| KALVISTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chairman Director/Board Member Director/Board Member Director/Board Member Founder Founder Corporate Officer/Principal Founder | |
Rockley Photonics Ltd.
 Rockley Photonics Ltd. SemiconductorsElectronic Technology Rockley Photonics Ltd. manufactures integrated optics, CMOS electronics, software and computer networking with silicon photonics. The company was founded by Andrew George Rickman and Aaron Zilkie in 2013 and is headquartered in Oxford, the United Kingdom. | Semiconductors | Director/Board Member | |
| Dermatology Innovation Forum | Founder | ||
Frazier Life Sciences Management LP
 Frazier Life Sciences Management LP Investment ManagersFinance Frazier Life Sciences Management LP (Frazier Life Sciences) is a private investment manager headquartered in Menlo Park, California. The firm was founded in 2021 as a newly spun off company from Frazier Management LLC. They are principally owned by Jamie Topper and Patrick Heron. Frazier Life Sciences provides discretionary investment management services to US private investment funds, Frazier Life Sciences Funds. | Investment Managers | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 36 |
| Regno Unito | 11 |
| Danimarca | 3 |
| Canada | 2 |
| Cina | 2 |
Settori
| Health Technology | 29 |
| Finance | 7 |
| Consumer Services | 5 |
| Commercial Services | 3 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 114 |
| Corporate Officer/Principal | 31 |
| Independent Dir/Board Member | 26 |
| Founder | 23 |
| Chairman | 18 |
Contatti più connessi
| Insiders | |
|---|---|
| Arnold Lewis Oronsky | 35 |
| Richard Aldrich | 31 |
| Albert Cha | 30 |
| Brian Pereira | 23 |
| Robert Tansley | 18 |
| Robert Rickman | 14 |
| Edward Unkart | 13 |
| Basil Omar | 8 |
| T. Crockett | 7 |
| Edward M. Green | 6 |
| Stephen Gerard Donnelly | 5 |
| Ed Feener | 4 |
| Christopher Yea | 4 |
| Lloyd Paul Aiello | 2 |
| Peter McPartland | 1 |
- Borsa valori
- Insiders
- Robert Haigh
- Connessioni Società
